Jose A S Crippa
Overview
Explore the profile of Jose A S Crippa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
797
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Batalla A, Lorenzetti V, Chye Y, Yucel M, Soriano-Mas C, Bhattacharyya S, et al.
Cannabis Cannabinoid Res
. 2018 Feb;
3(1):1-10.
PMID: 29404409
Hippocampal neuroanatomy is affected by genetic variations in dopaminergic candidate genes and environmental insults, such as early onset of chronic cannabis exposure. Here, we examine how hippocampal total and subregional...
12.
Nahler G, Grotenhermen F, Zuardi A, Crippa J
Cannabis Cannabinoid Res
. 2017 Sep;
2(1):81-86.
PMID: 28861507
Cannabidiol (CBD), a major cannabinoid of hemp, does not bind to CB1 receptors and is therefore devoid of psychotomimetic properties. Under acidic conditions, CBD can be transformed to delta9-tetrahydrocannabinol (THC)...
13.
Genaro K, Fabris D, Arantes A, Zuardi A, Crippa J, Prado W
Front Pharmacol
. 2017 Jul;
8:391.
PMID: 28680401
Pain involves different brain regions and is critically determined by emotional processing. Among other areas, the rostral anterior cingulate cortex (rACC) is implicated in the processing of affective pain. Drugs...
14.
Zuardi A, Rodrigues N, Silva A, Bernardo S, Hallak J, Guimaraes F, et al.
Front Pharmacol
. 2017 May;
8:259.
PMID: 28553229
The purpose of this study was to investigate whether the anxiolytic effect of cannabidiol (CBD) in humans follows the same pattern of an inverted U-shaped dose-effect curve observed in many...
15.
Crippa J, Crippa A, Hallak J, Martin-Santos R, Zuardi A
Front Pharmacol
. 2016 Oct;
7:359.
PMID: 27746737
Animal studies and preliminary clinical trials have shown that cannabidiol (CBD)-enriched extracts may have beneficial effects for children with treatment-resistant epilepsy. However, these compounds are not yet registered as medicines...
16.
Torres U, Duran F, Schaufelberger M, Crippa J, Louza M, Sallet P, et al.
Neuroimage Clin
. 2016 Jun;
12:1-15.
PMID: 27354958
Background: Structural brain abnormalities in schizophrenia have been repeatedly demonstrated in magnetic resonance imaging (MRI) studies, but it remains unclear whether these are static or progressive in nature. While longitudinal...
17.
Santos L, Loureiro S, Crippa J, Osorio F
PLoS One
. 2015 Mar;
10(3):e0121437.
PMID: 25811489
Background: The Liebowitz Social Anxiety Scale (LSAS) was the first evaluation instrument developed for screening for the signs and symptoms of Social Anxiety Disorder (SAD) and is currently still the...
18.
da Silva Ferreira G, Crippa J, Osorio F
Front Psychol
. 2015 Jan;
5:1460.
PMID: 25566138
Exposure to maltreatment is associated with biological, psychological, and social development impairments in children. This systematic literature review sought to determine whether an association exists between child maltreatment and facial...
19.
Maia-de-Oliveira J, Abrao J, Evora P, Zuardi A, Crippa J, Belmonte-de-Abreu P, et al.
J Clin Psychopharmacol
. 2014 Dec;
35(1):83-5.
PMID: 25502490
No abstract available.
20.
Linares I, Chags M, Machado-de-Sousa J, Crippa J, Hallak J
CNS Neurol Disord Drug Targets
. 2014 Jun;
13(6):1021-5.
PMID: 24923351
Specific phobia is an anxiety disorder characterized by irrational fear and avoidance of specific things or situations, interfering significantly with the patients' daily life. Treatment for the disorder consists of...